Market News AIOpen the app

Piper Sandler starts following Innoviva, giving it a positive rating and a price target of $29.

OpinionRead the original at marketscreener.com
Good for INVA

Piper Sandler began covering Innoviva, gave it an Overweight rating, and set a $29 target. This is a favorable analyst view, though it reports no change in Innoviva's business results.

INVA · Innoviva, Inc.

AI read · Good for INVA

The AI's read

The rating gives investors a favorable new outside view of Innoviva. It does not report a change in sales, profits, or operations, so the support comes from the analyst's view alone.

Get alerts for INVA

Follow Innoviva, Inc. (INVA) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for INVA
Free on the App Store and Google Play, or on the web.